BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34153032)

  • 1. Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads.
    Byrne CM; Johnston C; Orem J; Okuku F; Huang ML; Rahman H; Wald A; Corey L; Schiffer JT; Casper C; Coombs D; Gantt S
    PLoS Comput Biol; 2021 Jun; 17(6):e1009072. PubMed ID: 34153032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
    J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.
    de França TR; de Albuquerque Tavares Carvalho A; Gomes VB; Gueiros LA; Porter SR; Leao JC
    Clin Oral Investig; 2012 Apr; 16(2):659-64. PubMed ID: 22186943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
    Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
    BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection.
    Ueda S; Uchiyama S; Azzi T; Gysin C; Berger C; Bernasconi M; Harabuchi Y; Zinkernagel AS; Nadal D
    J Infect Dis; 2014 Jan; 209(2):255-64. PubMed ID: 23935199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection.
    Pereira LMS; França EDS; Costa IB; Lima IT; Freire ABC; Ramos FLP; Monteiro TAF; Macedo O; Sousa RCM; Freitas FB; Brasil Costa I; Vallinoto ACR
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.
    Santos L; Azevedo K; Silva L; Oliveira L
    Rev Assoc Med Bras (1992); 2014; 60(3):262-9. PubMed ID: 25004273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
    Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
    Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
    Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
    Front Immunol; 2018; 9():2291. PubMed ID: 30337929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
    Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
    J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
    Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
    J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study.
    Yan Y; Ren Y; Chen R; Hu J; Ji Y; Yang J; Shen J; Hu L; Pei H; Wang J; Qiu Y; Lu H; Huang L
    Virol Sin; 2018 Jun; 33(3):227-233. PubMed ID: 29654554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.
    Huynh GT; Rong L
    J Theor Biol; 2012 Oct; 310():105-14. PubMed ID: 22683365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
    Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
    J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
    Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
    J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
    Chaillon A; Nakazawa M; Rawlings SA; Curtin G; Caballero G; Scott B; Anderson C; Gianella S
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32641485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
    Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
    AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.